Credelio Quattro sharpens the pitch for one-chew parasite protection

Elanco’s Credelio Quattro is now being positioned as a one-monthly-chew option for “triple protection” in dogs, combining coverage for external parasites, heartworm prevention, and key intestinal parasites in a single oral product. The FDA approved Credelio Quattro in October 2024, and Elanco formally launched it at VMX 2025. The product is indicated for fleas, ticks, heartworm prevention, roundworms, hookworms, and tapeworms in dogs and puppies 8 weeks and older, with labeling that says it should be given with food and is available only through a licensed veterinarian. (elanco.com)

Why it matters: For veterinary teams, the message is less about a new parasite category than about simplification. A single monthly chew can reduce the need to layer multiple preventives, which may help improve adherence among pet parents, streamline clinic recommendations, and support broader year-round parasite protection conversations. That matters in a market where combination products are already competitive, and where convenience is often tied directly to compliance. (dvm360.com)

What to watch: Watch how strongly clinics adopt Credelio Quattro against entrenched combination products, and whether Elanco expands the product’s role following its separate conditional approval for New World screwworm treatment. (fda.gov)